CHRNA7 and obesity disorder: Our current study demonstrated for the first time that α7-nAChR agonist had insulin sensitizing action not only in normal mice, but also in insulin resistant mice, i.e., AMPKα2−/− mice, a model with no sign of inflammation and obesity, which is different from db/db mice [42].